Marriott Harrison advised Oxford Science Enterprises and others on the £30 million Series A round. Braavos Investment Advisers, Lansdowne Partners, Prosus Ventures, 2xN, Torch Partners and Hermann Hauser also participated.
Oxford Ionics, founded in 2019, is at the forefront of quantum computing technology development. The Oxford Ionics team comprises some of the brightest minds in quantum engineering, boasting 10 PhDs and 100 years of expertise between them. Unique to Oxford Ionics is its trapped-ion technology, which holds a number of world records.
Marriott Harrison was delighted to advise a number of leading quantum and tech investors on this exciting funding round, which was co-led by Oxford Science Enterprises and Braavos Investment Advisers.
Oxford Science Enterprises is an independent, billion-pound investment company created in 2015 to found, fund, and build transformational businesses via its unique partnership with the University of Oxford.
Braavos Investment Advisers is an early- to growth-stage venture capital firm based in London, which invests in companies founded on the premise of scientific and technological breakthroughs, with a particular focus on those linked to the University of Oxford.